ask="N/A"
ask_size="N/A"
average_daily_volume="249544"
bid="9.06"
bid_size="200"
book_value="2.66"
change="+0.15"
change_from_200_day_moving_average="1.00"
change_from_50_day_moving_average="-0.18"
change_from_52_week_high="-1.23"
change_From_52_week_low="2.84"
change_in_percent="+1.55%"
close="9.84"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.30"
ebitda="-117.58M"
eps_estimate_current_year="-2.03"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.73"
ex_dividend_date="N/A"
float_shares="15511000"
high="9.89"
high_52_weeks="11.07"
last_trade_date="2/9/2017"
last_trade_price="9.84"
last_trade_size="4858"
last_trade_time="4:00pm"
low="9.66"
low_52_weeks="7.00"
market_capitalization="180.07M"
moving_average_200_day="8.84"
moving_average_50_day="10.02"
name="Akebia Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.00"
open="9.74"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+11.26%"
percent_change_from_50_day_moving_average="-1.80%"
percent_change_from_52_week_high="-11.11%"
percent_change_from_52_week_low="+40.57%"
previous_close="9.69"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.65"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18300000"
short_ratio="3.69"
stock_exchange="NGM"
symbol="AKBA"
volume="132295"
weeks_range_52="7.00 - 11.07"
